E
HDRPF
vs
S&P 500
S&P 500
Over the past 12 months, HDRPF has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +15% growth.
Stocks Performance
HDRPF vs S&P 500
Performance Gap
HDRPF vs S&P 500
Performance By Year
HDRPF vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Epsilon Healthcare Ltd
Glance View
Epsilon Healthcare Ltd. manufactures and distributes hydroponics equipment, materials, and nutrients; and develops and delivers medical cannabis. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-05-04. The firm owns and operates end to end commercial medicinal cannabis production facilities. The firm operates through two segments: Manufacture and distribution of hydroponics equipment, materials and nutrients and development and delivery of medicinal cannabis. The firm also owns and operates turnkey cultivation solutions provider, including a hydroponics equipment and supplies wholesaler and retailer servicing the rapidly expanding cannabis sectors in North America and Europe.